Ky. Trinh et al., PERTURBATION OF FUEL HOMEOSTASIS CAUSED BY OVEREXPRESSION OF THE GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT IN LIVER OF NORMAL RATS, The Journal of biological chemistry, 273(47), 1998, pp. 31615-31620
The terminal step in hepatic gluconeogenesis is catalyzed by glucose-6
-phosphatase, an enzyme activity residing in the endoplasmic reticulum
and consisting of a catalytic subunit (glucose-6-phosphatase (G6Pase)
) and putative accessory transport proteins. We show that Zucker diabe
tic fatty rats (fa/fa), which are known to exhibit impaired suppressio
n of hepatic glucose output, have 2.4-fold more glucose-6-phosphatase
activity in liver than lean controls. To define the potential contribu
tion of increased hepatic G6Pase to development of diabetes, we infuse
d recombinant adenoviruses containing the G6Pase cDNA (AdCMV-G6Pase) o
r the beta-galactosidase gene into normal rats. Animals were studied b
y one of three protocols as follows: protocol I, fed ad libitum for 7
days; protocol 2, fed ad libitum for 5 days, fasted overnight, and sub
jected to an oral glucose tolerance test; protocol 3, fed ad libitum f
or 4 days, fasted for 48 h, subjected to oral glucose tolerance test,
and then allowed to refeed overnight. Hepatic glucose-6-phosphatase en
zymatic activity was increased by 1.6-3-fold in microsomes isolated fr
om AdCMV-G6Pase-treated animals in all three protocols, and the result
ant metabolic profile was similar in each case. AdCMV-GGPase-treated a
nimals exhibited several of the abnormalities associated with early st
age non-insulin-dependent diabetes mellitus, including glucose intoler
ance, hyperinsulinemia, decreased hepatic glycogen content, and increa
sed peripheral (muscle) triglyceride stores, These animals also exhibi
ted significant decreases in circulating free fatty acids and triglyce
rides, changes not normally associated with the disease. Our studies s
how that overexpression of G6Pase in liver is sufficient to perturb wh
ole animal glucose and lipid homeostasis, possibly contributing to the
development of metabolic abnormalities associated with diabetes.